CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CHRS — Coherus Oncology, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,719,296
-$234,176 QoQ
Shares Held
1,228,069
+6.2% QoQ
Ownership
0.795%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CHRS ranks #193 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in CHRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,719,296 | 1,228,069 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,953,472 | 1,155,901 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,328,039 | 935,239 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,628,670 | 993,092 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $717,382 | 981,372 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $767,195 | 950,676 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,348,062 | 976,857 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,002,900 | 964,327 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,467,230 | 848,110 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,647,011 | 689,126 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,556,431 | 767,697 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,705,411 | 723,372 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,262,771 | 529,923 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,455,855 | 505,242 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,013,768 | 506,789 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,731,416 | 492,343 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,446,218 | 475,997 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,035,489 | 467,505 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,584,782 | 475,237 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,510,443 | 467,358 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $6,578,626 | 475,678 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,822,037 | 466,943 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,814,666 | 507,173 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,440,918 | 514,772 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,046,231 | 618,490 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $10,147,280 | 625,603 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||